While Epitalon has been widely discussed in research literature, these investigations remain part of ongoing scientific study and should not be interpreted as evidence of established clinical or therapeutic benefit
Ipamorelin is studied for its selective action on growth hormone release, with minimal effect on cortisol, prolactin or other hormone pathways, making it a more targeted research subject than older-generation GH secretagogues
Very common (more than 1 in 10 people): mild pain, redness, or swelling at the injection site that usually fades within a day
It modulates gene expression broadly downregulating NF-B inflammatory programs while upregulating antioxidant and repair pathways
The quality of a compounded peptide depends entirely on the standards of the compounding pharmacy preparing it
Timothy Piatkowski, Senior Research Fellow in Public Health, The University of Queensland